In addition, the dynamic interaction between myeloma cells and the bone marrow environment [19] influences NF-κB signaling through cytokine-, chemokine- and growth factor-mediated loops, promoting the proliferation, survival, migration, and drug resistance of myeloma cells [20]. The gene discussed is NFKB1; the disease is plasma cell myeloma.